Researchers at Wake Forest have found a new treatment that may delay the onset of symptoms and increase the lifespan for those who are afflicted with ALS. The study was conducted in the mutant SOD1 mouse model of ALS and <a href=”/uploaded/Research WFU/Hsp70 project continue request Sept 2015.pdf”>plan to continue</a> to modify purification protocols, dosage studies in mice, and seek independent confirmation of effect. These studies will provide essential pre-clinical results so they can apply to move forward to patient studies (apply for an IND with the USFDA).
